← Axis Mutual Fund

Axis NIFTY Healthcare ETF

Index/ETF Data as of Oct 2026 Comparing Sep 2026 → Oct 2026
Share: WhatsApp X
Stocks Held
20
Oct 2026
Equity Holdings
₹23.50 Cr
Equity only, excl. debt & cash
Top 5 Weight
49.9%
High concentration
Top 10 Weight
76.4%
High concentration
Changes
20
0 new · 0 exits
Top Sector
Pharmaceuticals & Biotechnology
81.8% of portfolio
Launch Date
30 Apr 2021
5 years old
📋 What Happened This Month Among existing holdings, Laurus Labs Limited saw the biggest increase — now at 8.12% of the portfolio. Sun Pharmaceutical Industries Limited was trimmed the most, now at 16.32%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 81.8%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.
Sector Shift Industry allocation month-over-month
Aug 2026 → Sep 2026
Sector Prev Curr ▼ Delta
Pharmaceuticals & Biotechnology 80.7% 81.1% ▲ +0.4%
Healthcare Services 19.3% 18.9% ▼ -0.4%
Sep 2026 → Oct 2026
Sector Prev Curr ▼ Delta
Pharmaceuticals & Biotechnology 81.1% 81.8% ▲ +0.7%
Healthcare Services 18.9% 18.2% ▼ -0.7%
↑
Biggest Add
Laurus Labs Limited
+1.30% · now 8.12%
↓
Biggest Trim
Sun Pharmaceutical Industries Limited
-0.68% · now 16.32%

What Changed in the Portfolio This Month?

Comparing Sep 2026 → Oct 2026

Sep 2026 → Oct 2026
↑ 7 Increased ↓ 13 Decreased
#StockSectorSep 2026Oct 2026Change
1
Laurus Labs Limited
₹1.91 Cr
Pharmaceuticals & Biotechnology 6.82% 8.12% +1.30%
2
Dr. Reddy's Laboratories Limited
₹1.68 Cr
Pharmaceuticals & Biotechnology 6.65% 7.15% +0.50%
3
Divi's Laboratories Limited
₹2.53 Cr
Pharmaceuticals & Biotechnology 10.44% 10.78% +0.34%
4
Zydus Lifesciences Limited
₹62.91 L
Pharmaceuticals & Biotechnology 2.54% 2.68% +0.14%
5
Apollo Hospitals Enterprise Limited
₹1.77 Cr
Healthcare Services 7.43% 7.54% +0.11%
6
Gland Pharma Limited
₹50.31 L
Pharmaceuticals & Biotechnology 2.04% 2.14% +0.10%
7
Cipla Limited
₹1.58 Cr
Pharmaceuticals & Biotechnology 6.69% 6.73% +0.04%
#StockSectorSep 2026Oct 2026Change
1
Sun Pharmaceutical Industries Limited
₹3.84 Cr
Pharmaceuticals & Biotechnology 17.00% 16.32% -0.68%
2
Max Healthcare Institute Limited
₹1.30 Cr
Healthcare Services 6.12% 5.55% -0.57%
3
Torrent Pharmaceuticals Limited
₹1.38 Cr
Pharmaceuticals & Biotechnology 6.24% 5.89% -0.35%
4
Biocon Limited
₹49.98 L
Pharmaceuticals & Biotechnology 2.28% 2.13% -0.15%
5
Krishna Institute Of Medical Sciences Limited
₹38.18 L
Healthcare Services 1.76% 1.62% -0.14%
6
Lupin Limited
₹99.58 L
Pharmaceuticals & Biotechnology 4.36% 4.24% -0.12%
7
Glenmark Pharmaceuticals Limited
₹70.55 L
Pharmaceuticals & Biotechnology 3.11% 3.00% -0.11%
8
Abbott India Limited
₹27.17 L
Pharmaceuticals & Biotechnology 1.25% 1.16% -0.09%
9
Fortis Healthcare Limited
₹81.59 L
Healthcare Services 3.55% 3.47% -0.08%
10
Alkem Laboratories Limited
₹62.84 L
Pharmaceuticals & Biotechnology 2.75% 2.67% -0.08%

What Stocks Does This Fund Hold?

20 stocks — Oct 2026

# Stock Sector Cap Weight & Value
1
₹3.84 Cr
Pharmaceuticals & Biotechnology
16.32%
2
₹2.53 Cr
Pharmaceuticals & Biotechnology
10.78%
3
₹1.91 Cr
Pharmaceuticals & Biotechnology
8.12%
4
₹1.77 Cr
Healthcare Services
7.54%
5
₹1.68 Cr
Pharmaceuticals & Biotechnology
7.15%
6
₹1.58 Cr
Pharmaceuticals & Biotechnology
6.73%
7
₹1.38 Cr
Pharmaceuticals & Biotechnology
5.89%
8
₹1.30 Cr
Healthcare Services
5.55%
9
₹99.58 L
Pharmaceuticals & Biotechnology
4.24%
10
₹94.73 L
Pharmaceuticals & Biotechnology
4.03%
🏆 Top stocks held by Equity funds
See which stocks all active Equity fund managers are buying — ranked by total value invested
→
🏦 Axis Mutual Fund — Portfolio & Holdings
See all funds managed by Axis Mutual Fund — conviction stocks, monthly entries & exits
→

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.